Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bausch Health Companies Inc (NY: BHC )

7.580 -0.340 (-4.29%)
Official Closing Price Updated: 7:00 PM EDT, Mar 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,879,074
Open 7.960
Bid (Size) 7.460 (1)
Ask (Size) 8.000 (13)
Prev. Close 7.920
Today's Range 7.570 - 7.960
52wk Range 4.000 - 24.23
Shares Outstanding 358,808,755
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Bausch Health Announces Changes to its Board of Directors
Via ACCESSWIRE
Bausch Health's (BHC) Q4 Earnings & Sales Beat, Shares Up
The company’s adjusted earnings per share of $1.02, which beat the Zacks Consensus Estimate of 92 cents and our estimate of 84 cents but decreased from $1.29 reported in the year-ago quarter. 
Via Talk Markets

Performance

YTD
+20.70%
+20.70%
1 Month
-14.45%
-14.45%
3 Month
+11.47%
+11.47%
6 Month
+6.16%
+6.16%
1 Year
-67.95%
-67.95%

More News

Read More
Why Domino's Pizza Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why Bausch Health Shares Are Trading Higher Today
Via Benzinga
Bausch Health Announces Fourth-Quarter and Full-Year 2022 Results
Via ACCESSWIRE
Preview: Bausch Health Companies's Earnings
Via Benzinga
Comfort Systems, Gannett, CommScope And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Salix Announces 2023 Gastrointestinal Health Scholars Program
Via ACCESSWIRE
Bausch Health to Announce Fourth-Quarter and Full-Year 2022 Results on Feb. 23
Via ACCESSWIRE
'I Say, Move On': Cramer Prefers Nvidia Over This Cloud-Base Content Management Company Up 22%
Via Benzinga
Looking Into Bausch Health Companies's Return On Capital Employed
Via Benzinga
Bausch Health Companies's Return On Capital Employed Insights
Via Benzinga
Bausch Health Posts Q3 Profit Despite Lower Sales, Trims FY22 Outlook
Via Benzinga
7 Retirement Stocks to Buy Now OR You’ll Be Kicking Yourself Later
Via InvestorPlace
Most Active Equity Options For Midday - Monday, Jan. 23
Via Talk Markets
Battered FTX's CEO Sam Bankman-Fried Arrested, Elon Musk's SpaceX Mammoth Valuation Of $140B, China Weighs Over $143B In Semiconductor Push: Top Stories Tuesday, Dec. 13
Via Benzinga
Bausch Health Investors Request Blocking Eye-Care Business Spinoff, Alleging Protection From Lawsuits
Via Benzinga
Bausch Health Wins DUOBRII(R) and BRYHALI(R) Patent Infringement Case
Via ACCESSWIRE
Why Dollar General Shares Are Trading Lower By Over 8%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
PVH, Five Below, Okta And Some Other Big Stocks Moving Higher On Thursday
Via Benzinga
Salix Pharmaceuticals Culminates Year-Long Constipation Awareness Campaign with New Social Media and Digital Initiatives Empowering Patients to Discuss Their Symptoms with a Health Care Provider
Via ACCESSWIRE
Struggling Axsome Stock Could Bounce Back on Drug Trial Success
Via MarketBeat
Exposures Product Safety
Bausch Health Announces the Unrestricting of Bausch + Lomb Under Bausch Health Debt Documents
Via ACCESSWIRE
The Profit and Protection Quantitative Stock-Picking System
Via InvestorPlace
Salix Will Present Rifaximin Data at AASLD's The Liver Meeting(R) 2022
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.